TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biovac Sverige AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
23,756
|
29,594
|
28,390 |
| Financial expenses |
36
|
87
|
47 |
| Earnings before taxes |
336
|
1,019
|
-999 |
| EBITDA |
439
|
1,192
|
-867 |
| Total assets |
8,320
|
8,007
|
7,787 |
| Current assets |
7,140
|
6,600
|
6,287 |
| Current liabilities |
5,102
|
4,952
|
5,751 |
| Equity capital |
3,218
|
3,055
|
2,036 |
| - share capital |
49
|
50
|
50 |
| Employees (average) |
8
|
9
|
9 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
38.7%
|
38.2%
|
26.1% |
| Turnover per employee |
2,970
|
3,288
|
3,154 |
| Profit as a percentage of turnover |
1.4%
|
3.4%
|
-3.5% |
| Return on assets (ROA) |
4.5%
|
13.8%
|
-12.2% |
| Current ratio |
139.9%
|
133.3%
|
109.3% |
| Return on equity (ROE) |
10.4%
|
33.4%
|
-49.1% |
| Change turnover |
-4,859
|
1,058
|
-136 |
| Change turnover % |
-17%
|
4%
|
0% |
| Chg. No. of employees |
-1
|
0
|
1 |
| Chg. No. of employees % |
-11%
|
0%
|
13% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.